AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use--improves psoriasis in a human xenograft transplantation model.
Stenderup K, Rosada C, Shanebeck K, Brady W, Van Brunt MP, King G, Marelli M, Slagle P, Xu H, Nairn NW, Johnson J, Wang AA, Li G, Thornton KC, Dam TN, Grabstein KH.
Stenderup K, et al. Among authors: rosada c.
Protein Eng Des Sel. 2015 Oct;28(10):467-80. doi: 10.1093/protein/gzv034. Epub 2015 Aug 12.
Protein Eng Des Sel. 2015.
PMID: 26271488